---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-125344"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2025-12-31T23:59:59+00:00"
generated_at: "2026-05-16T11:54:07.155637+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Profound Medical closes $6.45M private placement of 921,428 shares at $7.00 each

## Summary
- Issued 921,428 common shares at US$7.00 per share to Canadian investors for gross proceeds of ~US$6.45M.
- Proceeds to be used for sales and marketing expansion, working capital, R&D, strategic transactions, and general corporate purposes.
- Shares subject to four-month-plus-one-day hold period under Canadian securities laws.
- Company to file resale registration statement with SEC within four months of closing.
- Offering closed on December 30, 2025, under Regulation S exemption from U.S. registration.

## SEC filing metadata
- accession: 0001104659-25-125344
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2025-12-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000110465925125344/0001104659-25-125344-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000110465925125344/tm2534550d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-125344
- JSON: https://secwatch.observer/filing/0001104659-25-125344.json
- Plain text: https://secwatch.observer/filing/0001104659-25-125344.txt

## Key facts
- Material Agreements
  Profound Medical Corp. entered into Subscription Agreement with certain Canadian investors valued at aggregate gross proceeds of $6.45 million (effective 2025-12-30).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain Canadian investors
  - Value: aggregate gross proceeds of $6.45 million
  - Effective: 2025-12-30
  source text: On December 30, 2025, Profound Medical Corp. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with certain Canadian investors (the “Investors”) providing for the private placement of an aggregate of 921,428 shares of the Company’s common shares (the “Shares”), at a per share purchase price of $7.00 (the “Offering”) for aggregate gross proceeds of $6.45 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628808/000110465925125344/0001104659-25-125344-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.